Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice

Journal of Hepatology

Volumn 56, Issue 1, 2012, Pages 248-254

  Song, Yiyun ^a   Shan, Shifang ^a   Zhang, Ying ^a   Liu, Wei ^a   Ding, Weiqiao ^a   Ren, Wenxia ^a   Xia, Hongfeng ^a   Li, Xiaojun ^a   Zhang, Qin ^b   Zhao, Lei ^c   Li, Xihua ^d   Yan, Jun ^e,f   Ying, Hao ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^e NANJING UNIVERSITY   (China)

^f WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic steatosis; Lipogenic gene; Steroid receptor coactivator; Thyroid hormone receptor; Transcriptional coregulator

Indexed keywords

COREPRESSOR PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; THYROID HORMONE RECEPTOR; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; CO-REPRESSOR PROTEINS; FATTY LIVER; HEK293 CELLS; HUMANS; LIGANDS; LIPOGENESIS; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, OBESE; MODELS, BIOLOGICAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA;

EID: 83555172601     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.07.014     Document Type: Article

References (30)

1. J. Sonoda, L.M. Pei, and R.M. Evans Nuclear receptors: decoding metabolic disease FEBS Lett 582 2008 2 9 (Pubitemid 350297241)
2. J.N. Feige, and J. Auwerx Transcriptional coregulators in the control of energy homeostasis Trends Cell Biol 17 2007 292 301 (Pubitemid 46829846)
3. A. Coste, J.F. Louet, M. Lagouge, C. Lerin, M.C. Antal, and H. Meziane The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1 alpha Proc Natl Acad Sci USA 105 2008 17187 17192
4. J.D. Lin, C. Handschin, and B.M. Spiegelman Metabolic control through the PGC-1 family of transcription coactivators Cell Metab 1 2005 361 370 (Pubitemid 43960626)
5. I. Astapovaa, L.J. Lee, C. Morales, S. Tauber, M. Bilban, and A.N. Hollenberg The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo Proc Natl Acad Sci USA 105 2008 19544 19549
6. R.R. Nofsinger, P. Li, S.H. Hong, J.W. Jonker, G.D. Barish, and H. Ying SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis Proc Natl Acad Sci USA 105 2008 20021 20026
7. M. Christian, R. White, and M.G. Parker Metabolic regulation by the nuclear receptor corepressor RIP140 Trends Endocrinol Metab 17 6 2006 243 250 (Pubitemid 44080617)
8. A. Palijan, I. Fernandes, M. Verway, M. Kourelis, Y. Bastien, and L.E. Tavera-Mendoza Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression J Biol Chem 284 2009 30275 30287
9. I. Fernandes, Y. Bastien, T. Wai, K. Nygard, R. Lin, and O. Cormier Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms Mol Cell 11 2003 139 150 (Pubitemid 36126597)
10. A. Palijan, I. Fernandes, Y. Bastien, L. Tang, M. Verway, and M. Kourelis Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR J Biol Chem 284 2009 30264 30274
11. P.M. Yen Physiological and molecular basis of thyroid hormone action Physiol Rev 81 2001 1097 1142 (Pubitemid 32606667)
12. G.A. Brent The molecular-basis of thyroid-hormone action N Engl J Med 331 1994 847 853
13. S.Y. Cheng Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance Trends Endocrinol Metab 16 2005 176 182
14. S.Y. Cheng, J.L. Leonard, and P.J. Davis Molecular aspects of thyroid hormone actions Endocr Rev 31 2010 139 170
15. X. Zhu, and S.Y. Cheng New insights into regulation of lipid metabolism by thyroid hormone Curr Opin Endocrinol Diabetes Obes 17 2010 408 413
16. F. Flamant, J.D. Baxter, D. Forrest, S. Refetoff, H. Samuels, and T.S. Scanlan International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors Pharmacol Rev 58 2006 705 711 (Pubitemid 44833740)
17. D. Forrest, L.C. Erway, L. Ng, R. Altschuler, and T. Curran Thyroid hormone receptor beta is essential for development of auditory function Nat Genet 13 1996 354 357 (Pubitemid 26230504)
18. L. Wikstrom, C. Johansson, C. Salto, C. Barlow, A.C. Barros, and F. Baas Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1 EMBO J 17 1998 455 461 (Pubitemid 28045486)
19. A.M. Zavacki, H. Ying, M.A. Christoffolete, G. Aerts, E. So, and J.W. Harney Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse Endocrinology 146 2005 1568 1575 (Pubitemid 40289348)
20. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432 (Pubitemid 24365442)
21. M. Kaneshige, K. Kaneshige, X. Zhu, A. Dace, L. Garrett, and T.A. Carter Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone Proc Natl Acad Sci USA 97 2000 13209 13214
22. W.J. Feng, R.C.J. Ribeiro, R.L. Wagner, H. Nguyen, J.W. Apriletti, and R.J. Fletterick Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors Science 280 1998 1747 1749 (Pubitemid 28283497)
23. T.C. Leone, J.J. Lehman, B.N. Finck, P.J. Schaeffer, A.R. Wende, and S. Boudina PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis PLoS Biol 3 2005 e101
24. J. Sonoda, I.R. Mehl, L.W. Chong, R.R. Nofsinger, and R.M. Evans PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis Proc Natl Acad Sci USA 104 2007 5223 5228 (Pubitemid 47186203)
25. G. Leonardsson, J.H. Steel, M. Christian, V. Pocock, S. Milligan, and J. Bell Nuclear receptor corepressor RIP140 regulates fat accumulation Proc Natl Acad Sci USA 101 2004 8437 8442 (Pubitemid 38736593)
26. X. Ma, L. Xu, S. Wang, B. Cui, X. Li, and J. Xu Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis J Hepatol 55 2 2011 445 452
27. Y.C. Sohn, S.W. Kim, S. Lee, Y.Y. Kong, D.S. Na, and S.K. Lee Dynamic inhibition of nuclear receptor activation by corepressor binding Mol Endocrinol 17 2003 366 372 (Pubitemid 36315631)
28. M.D. Erion, E.E. Cable, B.R. Ito, H. Jiang, J.M. Fujitaki, and P.D. Finn Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index Proc Natl Acad Sci USA 104 2007 15490 15495 (Pubitemid 47502944)
29. E.E. Cable, P.D. Finn, J.W. Stebbins, J. Hou, B.R. Ito, and P.D. van Poelje Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist Hepatology 49 2009 407 417
30. L.N. Wei, and X. Hu Receptor interacting protein 140 as a thyroid hormone-dependent, negative co-regulator for the induction of cellular retinoic acid binding protein I gene Mol Cell Endocrinol 218 2004 39 48 (Pubitemid 38569926)